Enzon Pharmaceuticals shares declined 11.23 percent on volume of 1.66 million shares traded to close at $3.40. After completing a review of strategic alternatives, the company Board of Directors has authorized a special dividend of $1.60 per share.
Going forward ... (see research report)
Copyright ® 2014. The Bedford Report. All Rights Reserved.